Northwestern Mutual Wealth Management CO Biotechnology

Northwestern Mutual Wealth Management CO

$121 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NVO Novo Nordisk A S	$147B	$28 Million 0.02% of portfolio	403,391	Q1 2025 Added 7.15%
VRTX Vertex Pharmaceuticals Inc	$119B	$6.32 Million 0.01% of portfolio	13,037	Q1 2025 Added 3.91%
PTGX Protagonist Therapeutics, Inc	$2.77B	$3.82 Million 0.0% of portfolio	78,894	Q3 2024 Reduced 50.0%
REGN Regeneron Pharmaceuticals, Inc.	$59B	$2.62 Million 0.0% of portfolio	4,133	Q1 2025 Added 7.74%
BMRN Biomarin Pharmaceutical Inc	$10.8B	$934,000 0.0% of portfolio	13,218	Q1 2025 Added 1.79%
MRNA Moderna, Inc.	$12.6B	$727,000 0.0% of portfolio	25,648	Q1 2025 Added 27.68%
INCY Incyte Corp	$15.3B	$515,000 0.0% of portfolio	8,509	Q1 2025 Added 8.77%
JAZZ Jazz Pharmaceuticals PLC	$7.2B	$426,000 0.0% of portfolio	3,434	Q1 2025 Added 21.43%
IONS Ionis Pharmaceuticals Inc	$5.99B	$372,000 0.0% of portfolio	12,358	Q1 2025 Added 9.1%
TGTX Tg Therapeutics, Inc.	$5.69B	$316,000 0.0% of portfolio	8,025	Q1 2025 Reduced 0.5%
RPRX Royalty Pharma PLC	$15.5B	$237,000 0.0% of portfolio	7,625	Q1 2025 Added 17.78%
CRSP Crispr Therapeutics Ag	$4.3B	$233,000 0.0% of portfolio	6,873	Q1 2025 Added 75.15%
KROS Keros Therapeutics, Inc.	$370M	$180,000 0.0% of portfolio	17,674	Q3 2024 New
XENE Xenon Pharmaceuticals Inc.	$2B	$167,000 0.0% of portfolio	5,000	Q1 2025 Reduced 0.38%
ALNY Alnylam Pharmaceuticals, Inc.	$39.9B	$141,000 0.0% of portfolio	525	Q1 2025 Added 10.29%
AVXL Anavex Life Sciences Corp.	$862M	$127,000 0.0% of portfolio	14,871	Q1 2025 Reduced 46.06%
UTHR United Therapeutics Corp	$13.5B	$114,000 0.0% of portfolio	373	Q1 2025 Added 8.75%
TECH Bio Techne Corp	$2.09B	$113,000 0.0% of portfolio	1,943	Q1 2025 Reduced 5.73%
VCEL Vericel Corp	$1.71B	$89,000 0.0% of portfolio	2,000	Q1 2025 Reduced 1.28%
BPMC Blueprint Medicines Corp	$7.73B	$76,000 0.0% of portfolio	869	Q1 2025 Added 1.76%
PTCT Ptc Therapeutics, Inc.	$3.47B	$74,000 0.0% of portfolio	1,453	Q3 2023 Reduced 1.82%
ARGX Argenx Se	$31.7B	$49,000 0.0% of portfolio	83	Q1 2025 Reduced 1.19%
BCRX Biocryst Pharmaceuticals Inc	$1.62B	$45,000 0.0% of portfolio	6,127	Q1 2025 Reduced 30.9%
AMRN Amarin Corp Plcuk	$6.37B	$44,000 0.0% of portfolio	5,000	Q2 2024 Reduced 5.48%
AXSM Axsome Therapeutics, Inc.	$4.81B	$44,000 0.0% of portfolio	382	Q4 2024 Added 10.72%
MNKD Mannkind Corp	$1B	$39,000 0.0% of portfolio	7,836	Q4 2024 New
VKTX Viking Therapeutics, Inc.	$2.46B	$39,000 0.0% of portfolio	1,628	Q1 2025 Added 3.04%
NTLA Intellia Therapeutics, Inc.	$899M	$32,000 0.0% of portfolio	4,590	Q1 2025 Added 56.39%
VCYT Veracyte, Inc.	$1.73B	$29,000 0.0% of portfolio	1,000	Q4 2024 Reduced 1.48%
HALO Halozyme Therapeutics, Inc.	$8.05B	$28,000 0.0% of portfolio	443	Q1 2025 Added 41.53%
OCGN Ocugen, Inc.	$217M	$28,000 0.0% of portfolio	40,000	Q1 2025 New
LGND Ligand Pharmaceuticals Inc	$2.32B	$21,000 0.0% of portfolio	200	Q4 2024 Reduced 65.69%
SRPT Sarepta Therapeutics, Inc.	$1.92B	$20,000 0.0% of portfolio	319	Q1 2025 Added 82.29%
BNTX Bio N Tech Se	$26.9B	$19,000 0.0% of portfolio	219	Q1 2025 Added 1.39%
INSM Insmed Inc	$14.1B	$19,000 0.0% of portfolio	262	Q1 2025 Added 589.47%
PCVX Vaxcyte, Inc.	$2.22B	$16,000 0.0% of portfolio	450	Q1 2025 Added 733.33%
XERS Xeris Biopharma Holdings, Inc.	$711M	$15,000 0.0% of portfolio	2,789	Q1 2025 New
APLS Apellis Pharmaceuticals, Inc.	$2.2B	$13,000 0.0% of portfolio	606	Q1 2025 Added 1.0%
VRCA Verrica Pharmaceuticals Inc.	$327M	$13,000 0.0% of portfolio	1,761	Q1 2025 New
CVAC Cure Vac N.V.	$1.01B	$12,000 0.0% of portfolio	4,461	Q1 2025 New
CUE Cue Biopharma, Inc.	$29.4M	$9,000 0.0% of portfolio	10,000	Q1 2025 Added 300.0%
IOVA Iovance Biotherapeutics, Inc.	$369M	$9,000 0.0% of portfolio	2,880	Q1 2025 Added 45.9%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$8.18M	$8,000 0.0% of portfolio	9,299	Q4 2021 New
BGNE Bei Gene, Ltd.	$23.5B	$7,000 0.0% of portfolio	31	Q1 2025 Reduced 34.04%
CHRS Coherus Bio Sciences, Inc.	$70M	$7,000 0.0% of portfolio	9,850	Q1 2025 Added 34.01%
MDXG Mimedx Group, Inc.	$763M	$7,000 0.0% of portfolio	1,000	Q3 2024 Reduced 50.0%
EYPT Eye Point Pharmaceuticals, Inc.	$351M	$5,000 0.0% of portfolio	1,000	Q1 2024 New
FOLD Amicus Therapeutics, Inc.	$1.76B	$3,000 0.0% of portfolio	479	Q1 2025 Added 5.51%
RNA Avidity Biosciences, Inc.	$1.77B	$3,000 0.0% of portfolio	115	Q1 2025 Added 721.43%
GERN Geron Corp	$487M	$3,000 0.0% of portfolio	2,000	Q1 2024 Reduced 11.7%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.